Eli Lilly’s scope in neuroscience is broadening to psychedelics through a deal to buy AtaiBeckley, a clinical-stage company whose lead program might offer advantages over a blockbuster Johnson & Johnson …
Health
-
-
Neko Health, a health tech company, announced Wednesday that it raised $700 million in Series C funding, which it will use to support its expansion into the U.S. The Swedish-based …
-
Advanced cases of breast cancer now have a new FDA-approved treatment option, a Celcuity drug whose first-in-a class approach could also have applications in a wider range of solid tumors. …
-
Digital health startups raised $7.4 billion during the first half of the year, up from $6.4 billion during the first half of 2025, according to data released this week by …
-
Claude Shannon, the father of information theory, famously defined information as “the resolution of uncertainty.” In healthcare analytics, our uncertainty is high not because we lack data (in fact, we …
-
Health plans are under pressure to do more on every front: deliver more personalized member experiences, improve quality and Stars performance, manage risk and payment accuracy, reduce administrative waste, and …
-
In just two years, Minnesota-based Fairview Health Services turned a $315 million annual loss into a nearly $600 million turnaround. Fairview lost money every year from 2019 to 2023, with …
-
The Coalition Against Surprise Medical Billing launched a “six-figure” ad campaign on Monday that calls on policymakers to reject the No Surprises Act Enforcement Act, which the organization argues will …
-
For decades, the diagnostic pathway for a patient with suspected obstructive sleep apnea (OSA) has followed a predictable sequence. The patient gets tested in a sleep lab overnight, a technician …
-
On Monday, Kaiser Permanente CEO Greg Adams took the stage at the American Hospital Association‘s Leadership Summit in Denver to make the case that his organization is cracking the code …